Pomalidomide-PEG4-azide

Pomalidomide-PEG4-azide

Pomalidomide-PEG4-azide contains a cereblon ligand, a hydrophilic PEG4 linker, and a terminal azide. This product is ready for conjugation to target proteins for PROTAC R&D. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-40498
    • Unit
    • Price
    • Qty
    • 50 MG
    • $320.00
    • 100 MG
    • $540.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Vartak, R., Deore, B., Sanhueza, C. A., & Patel, K. (2023). Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations. International Journal of Biological Macromolecules, 252, 126413.
    https://www.sciencedirect.com/science/article/abs/pii/S0141813023033093